Douglas Evan Godshall - 27 May 2022 Form 4 Insider Report for Shockwave Medical, Inc.

Role: President & CEO, Director
Signature: /s/ Wade Estey, as attorney-in-fact for Douglas Godshall
Issuer symbol: N/A
Transactions as of: 27 May 2022
Net transactions value: -$446,274
Form type: 4
Filing time: 01 Jun 2022, 19:01:28 UTC
Previous filing: 13 May 2022
Next filing: 08 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWAV	Common Stock	Options Exercise	$8,882	+2,600	+1.8%	$3.42	145,526	27 May 2022	Direct	F1
transaction	SWAV	Common Stock	Sale	$455,156	-2,600	-1.8%	$175.06	142,926	27 May 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWAV	Stock Option	Options Exercise	$0	-2,600	-0.56%	$0.000000	462,199	27 May 2022	Common Stock	2,600	$3.42	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022.
F2	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $175.00 to $175.26. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3	Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.